Now showing items 1-3 of 3

    • Thumbnail

      Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort 

      Mendel, Arielle; Bernatsky, Sasha B.; Hanly, John G.; Urowitz, Murray B.; Clarke, Ann Elaine; Romero Díaz, Juanita; Gordon, Caroline; Bae, Sang-Cheol; Wallace, Daniel J.; Merrill, Joan T.; Buyon, Jill P.; Isenberg, David A.; Rahman, Anisur; Ginzler, Ellen M.; Petri, Michelle; Dooley, Mary Anne; Fortin, Paul R.; Gladman, Dafna D.; Steinsson, Kristjan; Ramsey Goldman, Rosalind; Khamashta, Munther A.; Aranow, Cynthia; Mackay, Meggan; Alarcon, Graciela S.; Manzi, Susan; Nived, Ola; Jonsen, Andreas; Zoma, Asad A.; Ramos Casals, Manuel; Ruiz Irastorza, Guillermo; Lim, Sam; Kalunian, Ken C.; Inanc, Murat; Kamen, Diane L.; Peschken, Christine A.; Jacobsen, Soren; Askanase, Anca; Sánchez Guerrero, Jorge; Bruce, Ian N.; Costedoat Chalumeau, Nathalie; Vinet, Evelyne (BMJ Publishing, 2019-07)
      ...
    • Thumbnail

      Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus; a multi-center retrospective case-control study 

      Ferreira, Isabel; Croca, Sara; Raimondo, Maria Gabriella; Matharu, Manjit; Miller, Sarah; Giles, Ian; Isenberg, David; Ioannou, Yiannis; Hanly, John G.; Urowitz, Murray B.; Anderson, Nicole; Aranow, Cynthia; Askanase, Anca; Bae, Sang-Cheol; Bernatsky, Sasha; Bruce, Ian N.; Buyon, Jill; Clarke, Ann E.; Dooley, Mary Anne; Fortin, Paul R.; Ginzler, Ellen; Gladman, Dafna; Gordon, Caroline; Inanc, Murat; Jacobsen, Soren; Kalunian, Kenneth; Kamen, Diane; Khamashta, Munther; Lim, Sam; Manzi, Susan; Merrill, Joan; Nived, Ola; Peschken, Christine; Petri, Michelle; Ramsey Goldman, Rosalind; Ruiz Irastorza, Guillermo; Sanchez-Guerrero, Jorge; Steinson, Kristjan; Sturfelt, Gunnar K.; Van Vollenhoven, Ronald; Wallace, Daniel J.; Zoma, Asad; Rahman, Anisur (Biomed Central, 2017-12-22)
      Background: In patients with systemic lupus erythematosus (SLE) there is no serological test that will reliably distinguish neuropsychiatric (NP) events due to active SLE from those due to other causes. Previously we showed ...
    • Thumbnail

      Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus 

      Enocsson, Helena; Wirestam, Lina; Dahle, Charlotte; Padyukov, Leonid; Jonsen, Andreas; Urowitz, Murray B; Gladman, Dafna D; Romero Díaz, Juanita; Bae, Sang Cheol; Fortin, Paul R.; Sánchez Guerrero, Jorge; Clarke, Ann E; Bernatsky, Sasha; Gordon, Caroline; Hanly, John G; Wallace, Daniel J; Isenberg, David A; Rahman, Anisur; Merrill, Joan T; Ginzler, Ellen; Alarcón, Graciela S; Chatham, W Winn; Petri, Michelle; Khamashta, Munther; Aranow, Cynthia; Mackay, Meggan; Dooley, Mary Anne; Manzi, Susan; Ramsey Goldman, Rosalind; Nived, Ola; Steinsson, Kristjan; Zoma, Asad A; Ruiz Irastorza, Guillermo; Lim, S Sam; Kalunian, Kenneth C; Inanc, Murat; van Vollenhoven, Ronald F; Ramos Casals, Manuel; Kamen, Diane L; Jacobsen, Soren; Peschken, Christine A; Askanase, Anca; Stoll, Thomas; Bruce, Ian N; Wettero, Jonas; Sjowall, Christopher (Elsevier, 2019-10-17)
      OBJECTIVE: The soluble urokinase plasminogen activator receptor (suPAR) has potential as a prognosis and severity biomarker in several inflammatory and infectious diseases. In a previous cross-sectional study, suPAR levels ...